Preparation method and intermediate of nilotinib

A nilotinib, volumetric technology, applied in the field of drug synthesis, can solve the problems of many side reactions, expensive reagents, low product yield and purity

Active Publication Date: 2019-04-23
SHANGHAI SUNTECH PHARMA
View PDF7 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] The problem to be solved by the present invention is to provide a kind of nilotinib in order to overcome the defects of expensive reagents, potential safety hazards, cumbersome process, many side reactions, low product yield and purity in the existing method for preparing nilotinib. The preparation method of Lotinib and its intermediate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and intermediate of nilotinib
  • Preparation method and intermediate of nilotinib
  • Preparation method and intermediate of nilotinib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] Add respectively 3-amino-4-methylbenzoic acid methyl ester (16.5 grams, 0.10mol, 1.0 equivalents), di-tert-butyl dicarbonate (Boc 2 O, 21.8 g, 0.10 mol, 1.0 equivalent) and 100 ml of n-butanol. The reaction mixture was heated to 50-55° C. and stirred for 5-8 hours. High-efficiency liquid chromatography monitors that the reaction is complete. After adding 1000 grams of water to the reaction mixture, the system is concentrated to 100 milliliters. After the concentration is completed, it is filtered, and the filter cake is dried to obtain the nilotinib intermediate 3-((tert-butoxycarbonyl)amino) -25.5 g of methyl 4-methylbenzoate (Intermediate A), white to yellow solid, molar yield 96%.

Embodiment 2

[0085] Add respectively 3-amino-4-methylbenzoic acid methyl ester (33 grams, 0.2mol, 1.0 equivalents), di-tert-butyl dicarbonate (Boc2 O, 65.5 g, 0.3 mol, 1.5 equiv) and methanol 200 ml. The reaction mixture was heated to 60-65° C. and stirred for 6-10 hours. High-efficiency liquid chromatography monitors that the reaction is complete. After adding 3000 grams of water to the reaction mixture, the system is concentrated to 200 milliliters. After the concentration is completed, it is filtered, and the filter cake is dried to obtain the nilotinib intermediate 3-((tert-butoxycarbonyl)amino) - 47.8 g of methyl 4-methylbenzoate (Intermediate A), white to yellow solid, molar yield 90%.

Embodiment 3

[0087] Add respectively 3-amino-4-methylbenzoic acid methyl ester (16.5 grams, 0.1mol, 1.0 equivalents), di-tert-butyl dicarbonate (Boc 2 O, 24.0 g, 0.11 mol, 1.1 equiv) and 100 ml of ethanol. The reaction mixture was heated to 55-60° C. and stirred for 6-8 hours. High-efficiency liquid chromatography monitors that the reaction is complete. After adding 1000 grams of water to the reaction mixture, the system is concentrated to 100 milliliters. After the concentration is completed, it is filtered, and the filter cake is dried to obtain the nilotinib intermediate 3-((tert-butoxycarbonyl)amino) - 25.4 g of methyl 4-methylbenzoate (Intermediate A), white to yellow solid, molar yield 91%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a nilotinib preparation method and an intermediate of nilotinib. The preparation method comprises: in a solvent, carrying out a reaction defined in the specification on a compound D or a hydrochloride salt thereof, and a compound SM3 under the action of an inorganic base to obtain the compound E nilotinib. According to the present invention, the preparation method has characteristics of simple reaction, easy operation, safe and environmentally friendly reagent, less side reaction and short reaction time. The reaction formula is defined in the specification.

Description

technical field [0001] The invention relates to the field of drug synthesis, in particular to a preparation method of nilotinib and an intermediate thereof. Background technique [0002] Nilotinib is an oral tyrosine kinase inhibitor developed by Novartis, Switzerland. The monohydrochloride monohydrate of nilotinib was approved for marketing by the U.S. Food and Drug Administration (FDA) in October 2007, with a trade name of Tasigna. It is clinically used to treat chronic myeloid leukemia resistant to imatinib mesylate. The drug can selectively inhibit Philadelphia chromosome-positive chronic myelogenous leukemia caused by mutations in tyrosinase and its coding gene through targeting, or it is well tolerated and has a significant curative effect. [0003] In existing studies, many documents and patents have reported different synthetic methods of nilotinib. [0004] Patent US 7169791 reports the synthesis method of Nilotinib. The method adopts 3-amino-4-methylbenzoic aci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/14C07D233/61C07C271/28
CPCC07C271/28C07D233/61C07D401/14
Inventor 刘学军陈晓冬郝璐吴锋
Owner SHANGHAI SUNTECH PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap